Thyroid Cancer

Latest News

Active Surveillance Feasible for Papillary Thyroid Microcarcinomas

By

Hannah Dellabella

In healthy patients with papillary thyroid microcarcinomas, active surveillance may be a feasible and safe alternative to immediate surgery, according to study results published in The Journal of Clinical Endocrinology & Metabolism. There is controversy regarding optimal management of low-risk thyroid carcinomas, with active surveillance emerging as a potential alternative to surgery. However, there is…

The Different Pathways to Diagnosis and Treatment of Thyroid Microcarcinomas

By

Amit Akirov, MD

The diagnostic pathway leading to diagnosis of thyroid microcarcinoma (tumor size ≤1 cm) is very different than that of larger thyroid tumors.

Annual Postoperative Ultrasound May Not Be Necessary in Low-Risk Thyroid Cancer

By

Hannah Dellabella

Serum tumor markers alone can provide reliable surveillance of patients who undergo total thyroidectomy for low- and intermediate-risk papillary thyroid carcinoma.

Entractinib, a Tumor Agnostic Therapy, Receives FDA Approval

By

Brian Park, PharmD

Rozlytrek is a kinase inhibitor that selectively targets ROS1 and NTRK fusions.

Many Patients Perceive Lack of Choice in Receiving RAI for Thyroid Cancer

Many patients diagnosed with differentiated thyroid cancer perceive that they have no choice about receiving radioactive iodine.

Extranodal Extension May Indicate Intermediate Recurrence Risk in Papillary Thyroid Carcinoma

By

Endocrinology Advisor Contributing Writer

When the investigators included extranodal extension in the ATA’s current PTC risk stratification system, 32.8% of patients originally categorized as low risk with ≤5 positive lymph nodes were increased to intermediate risk.

Increased Incidence of Pediatric Thyroid Cancer in the United States

By

Hannah Dellabella

Incidence rates of pediatric thyroid cancer have increased in the United States, likely attributable to enhanced diagnostic practices and an increase in thyroid cancer in the pediatric population.

Overall Cancer Risk Increased in Patients With Type 2 Diabetes

Standardized incidence ratio highest for prostate cancer for men, nasopharynx cancer for women

Once-Weekly Exenatide Treatment Does Not Increase Risk for Medullary Thyroid Carcinoma

By

Amit Akirov, MD

Treatment with once-weekly exenatide 2 mg does not increase serum calcitonin concentrations or the risk for medullary thyroid carcinoma.

Cumulative Risk for Thyroid Cancer After Initial Benign Thyroid Biopsy

By

Tyler Rice

Patients who initially received negative thyroid biopsy results might face higher cumulative risk of developing thyroid cancer than that projected in previous literature.

Complication Rates Low for High-Volume Pediatric Thyroid Surgery

Complication rates are low following surgery for pediatric thyroid disease at a high-volume center.